LEADER 02775nam 2200613 a 450 001 9910955961503321 005 20251117091946.0 010 $a87-593-9800-0 010 $a87-593-9757-8 035 $a(CKB)2670000000254354 035 $a(EBL)3400820 035 $a(SSID)ssj0000738371 035 $a(PQKBManifestationID)12307152 035 $a(PQKBTitleCode)TC0000738371 035 $a(PQKBWorkID)10790445 035 $a(PQKB)11095181 035 $a(MiAaPQ)EBC3400820 035 $a(Au-PeEL)EBL3400820 035 $a(CaPaEBR)ebr10591858 035 $a(OCoLC)923361281 035 $a(BIP)79259122 035 $a(BIP)32237366 035 $a(EXLCZ)992670000000254354 100 $a20100521d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMethodology, technology and innovation in translation process research $ea tribute to Arnt Lykke Jakobsen /$fedited by Inger M. Mees, Fabio Alves, Susanne Go?pferich 205 $a1st ed. 210 $aFrederiksberg $cSamfundslitteratur$d2010 215 $a1 online resource (420 p.) 225 0$aCopenhagen studies in language,$x0905-9857 ;$v38 300 $aDescription based upon print version of record. 311 08$a87-593-1476-1 320 $a"Selected publications": p. 33-36. 320 $aIncludes bibliographical references. 327 $apt. 1. Methodological issues -- pt. 2. Computer assistance in process research -- pt. 3. Eye-tracking -- pt. 4. Precision, strategies and quality assessment. 330 $aThis volume contains ten papers describing various reading and translation experiments using eye-tracking techniques (sometimes combined with other process tools such as keystroke and pause logging methodology). Copenhagen Studies in Language volumes 36 and 37 (Behind the Mind edited by Susanne Gopferich, Arnt Lykke Jakobsen and Inger M. Mees) are two complementary volumes containing empirical studies by scholars working in the field of translation process research. Contributors include members of the EU Eye-to-IT project and the Graz longitudinal study as well as researchers from both Copenhagen Business School and a number of other universities worldwide. 606 $aTranslating and interpreting 615 0$aTranslating and interpreting. 701 $aJakobsen$b Arnt Lykke$01870148 701 $aMees$b Inger M$01870149 701 2$aMees$b Inger M$01870149 701 $aAlves$b Fa?bio$0931203 701 $aGo?pferich$b Susanne$0474456 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910955961503321 996 $aMethodology, technology and innovation in translation process research$94478505 997 $aUNINA LEADER 04780nam 2200721Ia 450 001 9910974006303321 005 20251116140746.0 010 $a9786610192038 010 $a9780309175234 010 $a0309175232 010 $a9781280192036 010 $a1280192038 010 $a9780309589680 010 $a0309589681 010 $a9780585026336 010 $a0585026335 035 $a(CKB)110986584751878 035 $a(SSID)ssj0000113212 035 $a(PQKBManifestationID)11140378 035 $a(PQKBTitleCode)TC0000113212 035 $a(PQKBWorkID)10099174 035 $a(PQKB)10107926 035 $a(MiAaPQ)EBC3376164 035 $a(Au-PeEL)EBL3376164 035 $a(CaPaEBR)ebr10055158 035 $a(OCoLC)923261208 035 $a(Perlego)4735814 035 $a(BIP)47279490 035 $a(EXLCZ)99110986584751878 100 $a19961009d1996 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aBlood and blood products $esafety and risk /$fForum on Blood Safety and Blood Availability, Division of Health Sciences Policy, Institute of Medicine ; Henrik Bendixen, Frederick Manning and Linette Sparacino, editors 205 $a1st ed. 210 $aWashington, D.C. $cNational Academy Press$d1996 215 $axviii, 186 p. $cill 300 $a"The talks summarized in this document were originally given at workshops on Current risks of disease transmission (July, 1994); Risk and regulation (January, 1995); and Managing threats to the blood supply (September, 1995)"--Foreword. 311 08$a9780309055833 311 08$a0309055830 320 $aIncludes bibliographical references. 327 $aBlood and Blood Products: Safety and Risk -- Copyright -- Foreword -- Preface -- Contents -- I Current Risks of Disease Transmission -- Blood and Blood Components: How Safe Are They Today? -- Viral Inactivation of Blood Products: A General Overview -- TRANSFUSION PLASMA -- BLOOD CELL CONCENTRATES -- RED BLOOD CELL CONCENTRATES -- PLATELET CONCENTRATES -- II Guarding the Blood Supply -- The Retrovirus Epidemiology Donor Study: Rationale and Methods -- Demographic and Serologic Characteristics of Volunteer Blood Donors -- CDC Surveillance of Donors -- DISCUSSION -- Surveillance of Recipients -- DISCUSSION -- CDC Surveillance of High-Risk Recipients -- DISCUSSION -- CDC Surveillance for Unknown Pathogens -- DISCUSSION -- III New Ideas for Safety and Monitoring -- Information Technology and Blood Safety -- Strategies for Dealing with Potentially Infected Recipients -- IV Risk Tolerance -- Beneficial Aspects of Surgical Transfusion -- Trade-off of the Risk of Hepatitis and the Benefit of Clotting Factor Concentrates in the 1970s and 1980s -- DISCUSSION -- Examples of Risks That We Tolerate -- DISCUSSION -- V Risk Communication -- A Mental Model Approach to Risk Communication -- DISCUSSION -- Risk Communication: Building Credibility -- ROLE OF INFORMATION -- THE ROLE OF RISK NUMBERS -- THE ROLE OF RISK COMPARISONS -- SOURCES OF CONFLICT -- DISCUSSION -- Attitudes Toward Risk: The Right to Know and the Right to Give Informed Consent -- DISCUSSION -- Patients, Informed Consent, and the Health Care Team -- DISCUSSION -- Communication of Risk and Uncertainty to Patients -- DISCUSSION -- VI No-Fault Insurance -- Administrative and "No-Fault" Systems for Compensating Medically Related Injuries -- The Colorado and Utah Models of Compensating Patient Injury -- DISCUSSION -- VII Concluding Remarks -- Henrik H. Bendixen -- Appendixes. 327 $aA Acronyms and Abbreviations -- B Workshop Participants -- WORKSHOP ON BLOOD BANK OPERATIONS July 23-24, 1994 -- WORKSHOP ON RISK AND REGULATION July 23-24, 1995 -- WORKSHOP ON MANAGING THREATS TO THE BLOOD SUPPLY September 21-22, 1995. 330 $aThis volume explores the safety and availability of the nation's supply of blood and blood components. It discusses the risks of disease transmission, methods of guarding the blood supply, new ideas on safety and monitoring, risk tolerance, risk communication, and no-fault insurance. 606 $aBlood banks$zUnited States$vCongresses 606 $aBlood$xCollection and preservation$vCongresses 606 $aBlood products$xSafety measures$vCongresses 615 0$aBlood banks 615 0$aBlood$xCollection and preservation 615 0$aBlood products$xSafety measures 676 $a362.1/784 701 $aBendixen$b Henrik$01811357 701 $aManning$b Frederick J$01806438 701 $aSparacino$b Linette R$01809298 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910974006303321 996 $aBlood and blood products$94363175 997 $aUNINA